|
1
|
Firestein GS: Etiology and pathogenesis of
rheumatoid arthtitis. Kelley’s Textbook of Rheumatology. Firestein
GS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Harris JED and
Sergent JS: 2. Saunders Elsevier; Philadelphia: pp. 1035–1086.
2009
|
|
2
|
Schuna AA and Megeff C: New drugs for the
treatment of rheumatoid arthritis. Am J Health Syst Pharm.
57:225–234. 2000.PubMed/NCBI
|
|
3
|
Ballou LR and Wang BWE: Nonsteroidal
anti-inflammatory drugs. Kelley’s Textbook of Rheumatology.
Firestein GS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Harris
JED and Sergent JS: 1. Saunders Elsevier; Philadelphia: pp.
833–861. 2009
|
|
4
|
Newman NM and Ling RS: Acetabular bone
destruction related to non-steroidal anti-inflammatory drugs.
Lancet. 2:11–14. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anastassiades T, Chopra R, Law C and Wong
E: In vitro suppression of transforming growth factor-β induced
stimulation of glycosaminoglycan synthesis by acetylsalicylic acid
and its reversal by misoprostol. J Rheumatol. 25:1962–1967.
1998.
|
|
6
|
Crolle G and D’Este E: Glucosamine
sulphate for the management of arthrosis: a controlled clinical
investigation. Curr Med Res Opin. 7:104–109. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pavelká K, Gatterová J, Olejarová M,
Machacek S, Giacovelli G and Rovati LC: Glucosamine sulphate use
and delay of progression of knee osteoarthritis: a 3-year,
randomized, placebo-controlled, double-blind study. Arch Intern
Med. 162:2113–2123. 2002.PubMed/NCBI
|
|
8
|
McAlindon TE, LaValley MP, Gulin JP and
Felson DT: Glucosamine and chondroitin for treatment of
osteoarthritis: a systematic quality assessment and meta-analysis.
JAMA. 283:1469–1475. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reginster JY, Deroisy R, Rovati LC, Lee
RL, Lejeun E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE and
Gossett C: Long-term effects of glucosamine sulfate on
osteoarthritis progression: a randomized, placebo-controlled
clinical trial. Lancet. 357:251–256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fenton JI, Chlebec-Brown KA, Peters TL,
Caron JP and Orth MW: Glucosamine HCl reduces equine articular
cartilage degradation in explant culture. Osteoarthritis Cartilage.
8:258–265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oegema TR Jr, Deloria LB, Sandy JD and
Hart DA: Effect of oral glucosamine on cartilage and meniscus in
normal and chymopapain-injected knees of young rabbits. Arthritis
Rheum. 46:2495–2503. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gouze JN, Bordji K, Gulberti S, Terlain B,
Netter P, Magdalou J, Fournel-Giqleux S and Ouzzine M:
Interleukin-1β down-regulates the expression of
glucuronosyl-transferase I, a key enzyme priming glycosaminoglycan
biosynthesis: influence of glucosamine on Interleukin-1β-mediated
effects in rat chondrocytes. Arthritis Rheum. 44:351–360. 2001.
|
|
13
|
Hua J, Sakamoto K, Kikukawa T, Abe C,
Kurosawa H and Nagaoka I: Evaluation of the suppressive actions of
glucosamine on the interleukin-1β-mediated activation of
synoviocytes. Inflamm Res. 56:432–438. 2007.PubMed/NCBI
|
|
14
|
Usha PR and Naidu MU: Randomised,
double-blind, parallel, placebo-controlled study of oral
glucosamine, methylsulfonylmethane and their combination in
osteoarthritis. Clin Drug Invest. 24:353–363. 2004. View Article : Google Scholar
|
|
15
|
Hasegawa T, Ueno S, Kumamoto S and
Yoshikai Y: Suppressive effect of methylsulfonylmethane (MSM) on
type II collagen-induced arthritis in DBA/1J mice. Jpn Pharmacol
Ther. 32:421–427. 2004.(In Japanese).
|
|
16
|
Kim YH, Kim DH, Lim H, Baek DY, Shin HK
and Kim JK: The anti-inflammatory effects of methylsulfonylmethane
on lipopolysaccharide-induced inflammatory responses in murine
macrophages. Biol Pharm Bull. 32:651–656. 2009. View Article : Google Scholar
|
|
17
|
Iouv M, Dumais G and du Souich P:
Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis
Cartilage. 16(Suppl 3): S14–S18. 2008. View Article : Google Scholar
|
|
18
|
Volpi N: Anti-inflammatory activity of
chondroitin sulphate: new functions from an old natural
macromolecule. Inflammopharmacology. 19:299–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zimmermann M: Ethical guidelines for
investigations of experimental pain in conscious animals. Pain.
16:109–110. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gryglewski RJ: Some experimental models
for the study of inflammation and anti-inflammatory drugs. Agents
Actions Suppl. 17–23. 1977.PubMed/NCBI
|
|
21
|
Hirano S, Wakazono K, Agata N, et al:
Effects of cytogenin, a novel anti-arthritic agent, on type II
collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in
Lewis rats. Int J Tissue React. 16:155–162. 1994.PubMed/NCBI
|
|
22
|
Wood FD, Pearson CM and Tanaka A: Capacity
of mycobacterial wax D and its subfractions to induce adjuvant
arthritis in rats. Int Arch Allergy Appl Immunol. 35:456–467. 1969.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jang D and Murrell GAC: Nitric oxide in
arthritis. Free Radic Biol Med. 24:1511–1519. 1998. View Article : Google Scholar
|
|
24
|
Setnikar I, Pacini MA and Revel L:
Antiarthritic effects of glucosamine sulfate studied in animal
models. Arzneimittelforschung. 41:542–545. 1991.PubMed/NCBI
|
|
25
|
Hua J, Suguro S, Hirano S, Sakamoto K and
Nagaoka I: Preventive actions of a high dose of glucosamine on
adjuvant arthritis in rats. Inflamm Res. 54:127–132. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakamura H, Masuko K, Yudoh K, Kato T,
Kamada T and Kawahara T: Effects of glucosamine administration on
patients with rheumatoid arthritis. Rheumatol Int. 27:213–218.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McInnes IB, Leung BP, Field M, Wei XQ,
Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R and Liew
FY: Production of nitric oxide in the synovial membrane of
rheumatoid and osteoarthritis patients. J Exp Med. 184:1519–1524.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crofford LJ, Wilder RL, Ristimäki AP, Sano
H, Remmers EF, Epps HR and Hla T: Cyclooxygenase-1 and -2
expression in rheumatoid synovial tissues. Effects of interleukin-1
beta, phorbolester, and corticosteroids. J Clin Invest.
93:1095–1101. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Najm WI, Reinsch S, Hoehler F, Tobis JS
and Harvey PW: S-adenosyl methionine (SAMe) versus celecoxib for
the treatment of osteoarthritis symptoms [ISRCTN36233495]: a
double-blind cross-over trial. BMC Musculoskelet Disord.
5:62004.PubMed/NCBI
|
